F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: Powerful correlation with survival and high impact on treatment

Cancer

Volumn 92, Issue 4, 2001, Pages 886-895

  Manus, Michael P Mac ^a   Hicks, Rodney J ^a   Ball, David L ^a   Kalff, Victor ^b   Matthews, Jane P ^a   Salminen, Eeva ^c   Khaw, Pearly ^a   Wirth, Andrew ^a   Rischin, Danny ^a   McKenzie, Alan ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Nonsmall cell lung carcinoma; Positron emission tomography; Radiation therapy; Survival analysis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DEVICE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PALLIATIVE THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035880709     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010815)92:4<886::AID-CNCR1397>3.0.CO;2-V     Document Type: Article

References (31)

1. Bronchogenic carcinoma: Analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling
2. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group
3. Positron emission tomography in the clinical evaluation of metastatic cancer
4. Whole-body 18-F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer
5. Lymph node staging in non-small cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients
6. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F] fluorodeoxyglucose
7. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta analystic comparison of PET and CT
8. Detection of extrathoracic metastases by positron emission tomography in lung cancer
9. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography
10. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non small cell lung cancer
11. Clinical impact of 18F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: A prospective study
12. Randomized controlled trial (RCT) to evaluate the cost-effectiveness of positron emission tomography (PET) added to conventional diagnosis in non-small cell lung cancer (NCLC)
13. The initial staging of non-small cell lung cancer: Value of routine radioisotope bone scanning
14. Continuous- slice PENN-PET: A positron tomograph with volume imaging capability
15. A new international staging system for lung cancer
16. Non-parametric estimation from incomplete observation
17. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
18. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: A randomised multicentre trial
19. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung
20. Intensity-modulated radiotherapy: Rethinking basic treatment planning paradigms
21. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality
22. High rate of detection of unsuspected distant metastases by PET in apparent Stage III non small cell lung cancer: Implications for radical radiation therapy
23. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung
24. Longer survival with higher doses of thoracic radiotherapy in patients with limited non-small cell lung cancer
25. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer
26. A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non small cell lung cancer: Final report of an Australian multicentre study
27. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung carcinoma: First analysis of a randomized trial in 353 patients
28. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable non-small cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04
29. Characteristics of 49 patients who survived for 5 years following radical radiation therapy for non-small cell lung cancer: The potential for cure